EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Predominance of multidrug-resistant Salmonella Typhi genotype 4.3.1 with low-level ciprofloxacin resistance in Zanzibar

Annette Onken iD, Sabrina Moyo, Mohammed Khamis Miraji, Jon Bohlin, Msafiri Marijani, Joel Manyahi, Kibwana Omar Kibwana, Fredrik Müller, Pål A Jenum, Khamis Ali Abeid, Marianne Reimers, Nina Langeland und 2 weitere

PLOS Neglected Tropical Diseases · 2024

DOI: 10.1371/journal.pntd.0012132 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2024. Verfasst von Annette Onken und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Science, University of Medicine, Bergen, Norway. Hauptthemen laut MEDLINE: Salmonella typhi, Ciprofloxacin, Drug Resistance, Multiple, Bacterial, Anti-Bacterial Agents. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Norwegian National Centre on Tropical Infectious Diseases, Haukeland Universitetssjukehus, Vestre Viken Hospital Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Typhoid fever is a common cause of febrile illness in low- and middle-income countries. While multidrug-resistant (MDR) Salmonella Typhi ( S . Typhi) has spread globally, fluoroquinolone resistance has mainly affected Asia.

Methods

Consecutively, 1038 blood cultures were obtained from patients of all age groups with fever and/or suspicion of serious systemic infection admitted at Mnazi Mmoja Hospital, Zanzibar in 2015–2016. S . Typhi were analyzed with antimicrobial susceptibility testing and with short read (61 strains) and long read (9 strains) whole genome sequencing, including three S . Typhi strains isolated in a pilot study 2012–2013.

Results

Sixty-three S . Typhi isolates (98%) were MDR carrying bla TEM-1B , sul1 and sul2 , dfrA7 and catA1 genes. Low-level ciprofloxacin resistance was detected in 69% (43/62), with a single gyrase mutation gyrA -D87G in 41 strains, and a single gyrA- S83F mutation in the non-MDR strain. All isolates were susceptible to ceftriaxone and azithromycin. All MDR isolates belonged to genotype 4.3.1 lineage I (4.3.1.1), with the antimicrobial resistance determinants located on a composite transposon integrated into the chromosome. Phylogenetically, the MDR subgroup with ciprofloxacin resistance clusters together with two external isolates.

Conclusions

We report a high rate of MDR and low-level ciprofloxacin resistant S . Typhi circulating in Zanzibar, belonging to genotype 4.3.1.1, which is widespread in Southeast Asia and African countries and associated with low-level ciprofloxacin resistance. Few therapeutic options are available for treatment of typhoid fever in the study setting. Surveillance of the prevalence, spread and antimicrobial susceptibility of S . Typhi can guide treatment and control efforts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Salmonella typhiCiprofloxacinDrug Resistance, Multiple, BacterialAnti-Bacterial AgentsTyphoid FeverGenotypeMicrobial Sensitivity TestsHumansTanzaniaAdolescentMaleChildAdultYoung AdultFemaleChild, PreschoolWhole Genome SequencingMiddle AgedInfantAged

Substanzen

CiprofloxacinAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Clinical Science, University of Medicine, Bergen, Norway.
  • National Centre for Tropical Infectious Diseases, Haukeland University Hospital, Bergen, Norway.
  • Department of Microbiology, Vestre Viken Hospital Trust, Drammen, Norway.
  • Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
  • Department of Internal Medicine, Mnazi Mmoja Hospital, Zanzibar, Tanzania.
  • Department of methods and analysis, Section of modelling and bioinformatics, Domain of Infection Control, Oslo, Norway.

ORCID-Profile: Annette Onken

Förderung

  • Norwegian National Centre on Tropical Infectious Diseases
  • Haukeland Universitetssjukehus
  • Vestre Viken Hospital Trust
  • Western Norway Regional Health Authority
  • Helse Vest Regionalt Helseføretak
  • CAMRIA - Combatting Anti-Microbial Resistance with Interdisciplinary Approaches, Centre for Antimicrobial Resistance in Western Norway, funded by Trond Mohn Fo…
  • STRESST - Antimicrobial Stewardship in Hospitals, Resistance Selection and Transfer in a One Health Context, University of Bergen funded by JPIAMR

Zitieren

APA

Onken, A., Moyo, S., Miraji, M. K., Bohlin, J., Marijani, M., Manyahi, J., Kibwana, K. O., Müller, F., Jenum, P. A., Abeid, K. A., Reimers, M., Langeland, N., Mørch, K., & Blomberg, B. (2024). Predominance of multidrug-resistant Salmonella Typhi genotype 4.3.1 with low-level ciprofloxacin resistance in Zanzibar. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0012132

Vancouver

Onken A, Moyo S, Miraji MK, Bohlin J, Marijani M, Manyahi J, et al. Predominance of multidrug-resistant Salmonella Typhi genotype 4.3.1 with low-level ciprofloxacin resistance in Zanzibar. PLOS Neglected Tropical Diseases. 2024. doi:10.1371/journal.pntd.0012132

BibTeX
@article{Onken2024,
  author = {Onken, Annette and Moyo, Sabrina and Miraji, Mohammed Khamis and Bohlin, Jon and Marijani, Msafiri and Manyahi, Joel and Kibwana, Kibwana Omar and Müller, Fredrik and Jenum, Pål A and Abeid, Khamis Ali and Reimers, Marianne and Langeland, Nina and Mørch, Kristine and Blomberg, Bjørn},
  title = {Predominance of multidrug-resistant Salmonella Typhi genotype 4.3.1 with low-level ciprofloxacin resistance in Zanzibar},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2024},
  doi = {10.1371/journal.pntd.0012132}
}
Kostenlos starten →